Prednisolone Acetate
Rank #206 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$68.8M
Total Cost
1,486,663
Total Claims
$68.8M
Total Cost
12,135
Prescribers
$46
Cost per Claim
907,929
Beneficiaries
1,910,772
30-Day Fills
$5,673
Avg Cost/Provider
123
Avg Claims/Provider
Share of Medicare Part D Spending
0.02%
of total Medicare Part D spending
$68.8M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $68.8M total
Top Prescribers of Prednisolone Acetate
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Ashley Guzman | Nurse Practitioner | Fontana, CA | 2,369 | $187K |
| 2 | Michael Pisacano | Ophthalmology | Bronx, NY | 2,814 | $178K |
| 3 | Bingjing Roberts | Ophthalmology | New York, NY | 4,047 | $150K |
| 4 | Gang Hu | Ophthalmology | Hurst, TX | 1,701 | $132K |
| 5 | Mark Fromer | Ophthalmology | New York, NY | 2,241 | $120K |
| 6 | David Seamont | Ophthalmology | Fort Lauderdale, FL | 2,061 | $111K |
| 7 | Harry Koster | Ophthalmology | Richmond Hill, NY | 1,588 | $99K |
| 8 | Joann Kang | Ophthalmology | Bronx, NY | 1,529 | $88K |
| 9 | Richard Cape | Ophthalmology | Dyersburg, TN | 1,641 | $86K |
| 10 | Michael Pohlod | Ophthalmology | Orlando, FL | 1,360 | $83K |
| 11 | Jeremy Cotliar | Ophthalmology | New York, NY | 1,464 | $80K |
| 12 | Faisel Ahmad | Ophthalmology | Marion, IL | 2,489 | $79K |
| 13 | Erik Letko | Ophthalmology | Lafayette, CO | 1,543 | $78K |
| 14 | Kevin Yuhan | Ophthalmology | Anaheim, CA | 982 | $77K |
| 15 | Nossonal Kleinfeldt | Ophthalmology | Livonia, MI | 1,273 | $76K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 203 | Mirtazapine (Mirtazapine) | $70.2M | 3,166,739 |
| 204 | Immun Glob G(Igg)-Ifas/Glycine (Panzyga) | $70.1M | 4,693 |
| 205 | Buprenorphine Hcl (Buprenorphine Hcl) | $69.7M | 205,349 |
| 206 | Prednisolone Acetate (Prednisolone Acetate) | $68.8M | 1,486,663 |
| 207 | Tenofovir Alafenamide (Vemlidy) | $68.7M | 44,509 |
| 208 | Abaloparatide (Tymlos) | $68.4M | 24,417 |
| 209 | Treprostinil Diolamine (Orenitram Er) | $68.2M | 5,964 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology